PSC

Patient Square Capital Portfolio holdings

AUM $564M
1-Year Est. Return 261.3%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+261.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$467M
AUM Growth
+$93.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1
+$22.7M
2
+$14M
3
+$8.99M
4
COGT icon
Cogent Biosciences
COGT
+$8.92M
5
TERN
Terns Pharmaceuticals
TERN
+$7.4M

Top Sells

1
+$85.1M
2
+$11.6M
3
+$10.8M
4
AGIO icon
Agios Pharmaceuticals
AGIO
+$5.37M
5
LQDA icon
Liquidia Corp
LQDA
+$4.93M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCUS icon
26
Arcus Biosciences
RCUS
$2.92B
$4.05M 0.87%
+170,000
CATX icon
27
Perspective Therapeutics
CATX
$346M
$3.12M 0.67%
1,132,815
+783,492
HROW icon
28
Harrow
HROW
$1.24B
$345K 0.07%
+7,031
QURE icon
29
uniQure
QURE
$1.67B
– –
-75,000
AGIO icon
30
Agios Pharmaceuticals
AGIO
$1.68B
– –
-133,827
CDTX
31
DELISTED
Cidara Therapeutics
CDTX
– –
-121,000
GERN icon
32
Geron
GERN
$751M
– –
-845,000
NRIX icon
33
Nurix Therapeutics
NRIX
$1.51B
– –
-437,237
1
2